Duality Advisers, LP Sarepta Therapeutics, Inc. Transaction History

Duality Advisers, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$67.31 - $124.76 $1.94 Million - $3.6 Million	28,830 New	28,830 $2.78 Million
Q2 2023 Jul 31, 2023	SELL	$106.4 - $157.19 $1.81 Million - $2.67 Million	-17,001 Reduced 88.91%	2,120 $242,000
Q1 2023 Jun 27, 2023	SELL	$117.53 - $155.99 $275,137 - $365,172	-2,341 Reduced 10.91%	19,121 $2.64 Million
Q4 2022 Feb 07, 2023	BUY	$100.86 - $132.13 $1.93 Million - $2.53 Million	19,166 Added 834.76%	21,462 $2.78 Million
Q3 2022 Nov 03, 2022	SELL	$75.71 - $119.24 $713,188 - $1.12 Million	-9,420 Reduced 80.4%	2,296 $254,000
Q2 2022 Aug 08, 2022	BUY	$62.69 - $88.44 $185,875 - $262,224	2,965 Added 33.88%	11,716 $878,000
Q1 2022 May 09, 2022	BUY	$63.15 - $90.42 $552,625 - $791,265	8,751 New	8,751 $684,000
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $376,422 - $880,229	-5,210 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$125.56 - $178.74 $293,810 - $418,251	2,340 Added 81.53%	5,210 $888,000
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $960,137 - $1.3 Million	-7,553 Reduced 72.46%	2,870 $403,000
Q2 2020 Jul 29, 2020	BUY	$93.0 - $171.7 $969,339 - $1.79 Million	10,423 New	10,423 $1.67 Million
Q4 2019 Feb 10, 2020	SELL	$76.53 - $135.58 $9.95 Million - $17.6 Million	-129,950 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$72.81 - $156.91 $9.46 Million - $20.4 Million	129,950 New	129,950 $9.79 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.